drugset / Trial / NCT07518459

A Study of Absorption, Distribution, Metabolism and Excretion (ADME) of [14C]AZD4144

NCT07518459

Phase 1 Completed 16 enrolled AstraZeneca Quotient Sciences · collab
Non-randomizedParallel-groupOpen-labelTreatment

Summary

This study in healthy volunteers aims to explore blood levels and side effects of the test medicine, and look at how it is broken down when injected into a vein or given as a liquid by mouth. The test medicine will be radiolabeled with a small amount of carbon-14 so it can be tracked in the body. This study will take place at one site in Nottingham, United Kingdom, and will enroll 2 groups of 8 healthy men aged 30-65 years.

Timeline

Start
2026-02-11
Primary completion
2026-05-26
Completion
2026-05-26

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD4144 Unknown Intravenous

Indications

No indication recorded.